• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Man Hung, PhD

Latest:

Will Regional Differences in Family Practice Procedures Impact Reimbursement Rates? A National Study of Medicare Part B

Analysis of 77,462 family practice providers showed large regional differences in types of procedures performed, and significant differences in submitted charges and payments, across regions.


Ruth Oratz, MD, FACP

Latest:

Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer

A decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.





G. Caleb Alexander, MD, MS

Latest:

Medicare Advantage Coverage Restrictions for the Costliest Physician-Administered Drugs

Four large Medicare Advantage insurers manage access to expensive physician-administered drugs with a combination of prior authorization, step therapy, and Part D formulary design.



Eric A. Jackson, PharmD

Latest:

Health Information Technology and Physicians' Knowledge of Drug Costs

High rates of health information technology use by physicians were only modestly associated with better knowledge of drug costs.


CEO, National Quality Forum

Latest:

Making Measurement Meaningful

A discussion on meaningful measurement and driving greater value in healthcare, and the role of the National Quality Forum.


Adam E. Cannon, MPH

Latest:

Improving Pneumococcal and Herpes Zoster Vaccination Uptake: Expanding Pharmacist Privileges

States offering pharmacists full immunization privileges have significantly higher vaccination uptake rates for pneumococcal disease and herpes zoster than states with restricted or no authorization.



L. Gregory Pawlson, MD, MPH

Latest:

A Comparison of Relative Resource Use and Quality in Medicare Advantage Health Plans Versus Traditional Medicare

Compared with traditional Medicare, relative resource use for those with diabetes or cardiovascular disease is lower in Medicare Advantage, while quality of care is higher.







CEO, Patient Access Network Foundation

Latest:

Rising Out-of-Pocket Costs Threaten an Already Vulnerable Population: An Introduction to the PAN Foundation and AJMC® Collaborative Supplement

This supplement showcases the winning papers from the PAN Challenge, which aimed to foster conversations about how to rein in out-of-pocket costs to eliminate barriers between patients and their critical medical treatments.



Blase N. Polite, MD, MPP

Latest:

Oncology Alternative Payment Models: Lessons From Commercial Insurance

Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date.


John Rotrosen, MD

Latest:

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification

The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).


Neal Shore, MD

Latest:

Final Insights on Current Bladder Cancer Clinical Trials

Neal Shore, MD, FACS, shares his final thoughts on the current landscape of clinical trials for both non-muscle-invasive bladder cancer and muscle-invasive bladder cancer, providing insights into the potential impact and future directions of these studies.


Charles Ruetsch, PhD

Latest:

A Claims-Based Algorithm to Reduce Relapse and Cost in Schizophrenia

Implementing a claims-based algorithm and disease management program may be an effective strategy to reduce relapse and cost among patients with schizophrenia.



Becky Y. K. Tsui, MPH

Latest:

Screening Cardiac Surgery Patients for MRSA: An Economic Computer Model

Routine preoperative MRSA screening of cardiac surgery patients could provide substantial economic value to third-party payers and hospitals under a wide range of circumstances.


Javier Lugo, MD

Latest:

Managing Inappropriate Requests of Laboratory Tests: From Detection to Monitoring

This study shows automatic, practical, simple, and effective strategies designed in the laboratory, in consensus with requesting clinicians, to improve laboratory test appropriateness.


Eric A. Finkelstein, PhD, MHA

Latest:

Return on Investment for Bariatric Surgery

This editorial discusses the cost implication of bariatric surgery and whether or not return on investment analysis should be used to make coverage decisions.



Clemens Hong, MD, MPH

Latest:

Implementing a Hybrid Approach to Select Patients for Care Management: Variations Across Practices

Hybrid approaches allow for clinician input into case finding for care management, but training and monitoring is required to protect against unintentional biases.


Veena Raghavan, MPH

Latest:

Promoting Electronic Health Record Adoption Among Small Independent Primary Care Practices

Substantial outreach efforts are needed in addition to offering subsidies or incentives in engaging primary care providers to adopt electronic health records.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.